Industry Insight: An interview with Søren Morgenthaler Echwald
2 August 2008 | By
European Pharmaceutical Review speaks to Søren Morgenthaler Echwald, Vice President of Business Development at Exiqon regarding new developments in microRNA.
List view / Grid view
2 August 2008 | By
European Pharmaceutical Review speaks to Søren Morgenthaler Echwald, Vice President of Business Development at Exiqon regarding new developments in microRNA.
25 January 2007 | By Dr. Ina K. Dahlsveen, Exiqon
The last few years have seen a rush of discoveries within a new field of post-transcriptional gene regulation. microRNAs, or miRNAs for short, are small regulating RNAs akin to small interfering RNAs (siRNA), but which are naturally expressed in vivo. Originally discovered in C. elegans 14 years ago, these small…